Sensitivity to antibacterials of Staphylococcus aureus isolated from different types of skin infections

Journal of International Medical Research

Volumn 25, Issue 1, 1997, Pages 1-7

  Nishijima, S ^a,d   Namura, S ^a   Nakagawa, M ^a   Kurokawa, I ^b   Kawabata, S ^c  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Tsukaguchi Prefectural Hospital   (Japan)

^c OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^d KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Antibacterial drugs; Methicillin resistant Staphylococcus aureus; Minimal inhibitory concentration; Skin infections; Staphylococcus aureus

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFACLOR; CEFPODOXIME PROXETIL; CLINDAMYCIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; METICILLIN; MINOCYCLINE; NADIFLOXACIN; OFLOXACIN; TOSUFLOXACIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DECUBITUS; ECZEMA; FOLLICULITIS; IMPETIGO; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; ULCER;

EID: 0031016104     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059702500101     Document Type: Article

References (10)

1. Nishijima S, Namura S, Mitsuya K, et al: Retrospective study of bacteria isolated from skin infections during the past 15 years (1977 - 1991) at Kansai Medical University. Jpn J Dermatol 1993; 103: 1988-1991.
2. Akiyama H, Yamada T, Simoe K, et al: Characteristics and susceptibilities to antimicrobial agents of Staphylococcus aureus isolates isolated in dermatology. Chemotherapy 1990; 38: 9-20.
3. Nishijima S, Namura S, Mitsuya K, et al: The incidence of isolation of methicillin-resistant Staphylococcus aureus (MRSA) strain from skin infections during the past three years (1989 - 1991). J Dermatol (Tokyo) 1993; 20: 193-197.
4. Nishijima S, Namura S, Akamatsu H, et al: Activity of eight fluoroquinolones against both methicillin-susceptible and -resistant Staphylococcus aureus isolated from skin infections. J Dermatol (Tokyo) 1995; 22: 153-155.
5. Takahashi H, Shoji S, Kikuchi H, et al: Changes in susceptibility of clinical isolates of Staphylococcus aureus to quinolones and other antibacterial agents from 1986 to 1993. Jpn J Chemother 1995; 43: 547-550.
6. Japan Society of Chemotherapy: Revised standardized method for determination of the minimum inhibitory concentrations in bacteria. Chemotherapy 1981; 29: 76-79.
7. Kanzaki H, Akiyama H, Kanamoto A, et al: Outburst of fusidic acid resistant Staphylococcus aureus. Jpn J Dermatol 1989; 99: 507-590.
8. Coskey RJ, Coskey LA: Diagnosis and treatment of impetigo. J Am Acad Dermatol 1987; 17: 62-62.
9. Shimoe K, Makino E, Torigoe R, et al: Characteristics and susceptibility to antimicrobial agents of Staphylococcus aureus isolated in dermatology. Jpn J Dermatol 1995; 105: 131-137.
10. Akiyama H, Shimoe K, Tada J, et al: Detection of Staphylococcus aureus in various skin diseases. Jpn J Dermatol 1993; 103: 1315-1322.